CN105732528A - 2-芳胺-4-二甲胺-1,3,5-三嗪类化合物的制备方法 - Google Patents
2-芳胺-4-二甲胺-1,3,5-三嗪类化合物的制备方法 Download PDFInfo
- Publication number
- CN105732528A CN105732528A CN201610178273.4A CN201610178273A CN105732528A CN 105732528 A CN105732528 A CN 105732528A CN 201610178273 A CN201610178273 A CN 201610178273A CN 105732528 A CN105732528 A CN 105732528A
- Authority
- CN
- China
- Prior art keywords
- preparation
- formula
- compound
- iii
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 150000001875 compounds Chemical class 0.000 claims abstract description 23
- 238000006243 chemical reaction Methods 0.000 claims abstract description 14
- 239000002904 solvent Substances 0.000 claims abstract description 12
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052802 copper Inorganic materials 0.000 claims abstract description 8
- 239000010949 copper Substances 0.000 claims abstract description 8
- 239000003054 catalyst Substances 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims abstract description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- KVKFRMCSXWQSNT-UHFFFAOYSA-N n,n'-dimethylethane-1,2-diamine Chemical group CNCCNC KVKFRMCSXWQSNT-UHFFFAOYSA-N 0.000 claims description 6
- -1 methoxyl group Chemical group 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 238000004440 column chromatography Methods 0.000 claims description 3
- 239000003480 eluent Substances 0.000 claims description 3
- 239000012044 organic layer Substances 0.000 claims description 3
- 239000000376 reactant Substances 0.000 claims description 3
- 125000002774 3,4-dimethoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1OC([H])([H])[H])C([H])([H])* 0.000 claims description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 229910052801 chlorine Chemical group 0.000 claims description 2
- 239000000460 chlorine Chemical group 0.000 claims description 2
- 230000006837 decompression Effects 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical group 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 238000012805 post-processing Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 239000003446 ligand Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- YCOXTKKNXUZSKD-UHFFFAOYSA-N as-o-xylenol Natural products CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 description 6
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- 150000003918 triazines Chemical class 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- PHRJJOSPUYLRST-UHFFFAOYSA-N 2-n,2-n-dimethyl-6-phenyl-1,3,5-triazine-2,4-diamine Chemical class CN(C)C1=NC(N)=NC(C=2C=CC=CC=2)=N1 PHRJJOSPUYLRST-UHFFFAOYSA-N 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- SYSZENVIJHPFNL-UHFFFAOYSA-N (alpha-D-mannosyl)7-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine, isoform B (protein) Chemical compound COC1=CC=C(I)C=C1 SYSZENVIJHPFNL-UHFFFAOYSA-N 0.000 description 1
- IILRCRRCAGMZFE-UHFFFAOYSA-N CN(C)c1nc(C2=CC=CC=C=C2)nc(Nc2ccccc2)n1 Chemical compound CN(C)c1nc(C2=CC=CC=C=C2)nc(Nc2ccccc2)n1 IILRCRRCAGMZFE-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000007529 inorganic bases Chemical group 0.000 description 1
- JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical class N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
- C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
本发明提供了一种式(III)所示的2?芳胺?4?二甲胺?1,3,5?三嗪类化合物的制备方法,所述的制备方法为:在反应容器中,加入式(I)所示化合物、式(II)所示化合物、金属铜催化剂、配体、碱性物质和溶剂,在80~140℃下搅拌反应6~14h,之后反应液经后处理,制得式(III)所示产物;该工艺反应条件温和,操作方便,成本低,有着广泛的工业应用前景。
Description
(一)技术领域
本发明涉及一种2-芳胺-4-二甲胺-1,3,5-三嗪类化合物的制备方法。
(二)背景技术
均三嗪类化合物不仅是被广泛应用于医药、纺织、橡胶等行业的重要有机合成中间体,同时也具有抗菌、抗癌等多种生物活性,因此,研究该类化合物的制备方法具有重要的理论意义和实际应用价值。
(三)发明内容
本发明的目的是提供一种2-芳胺-4-二甲胺-1,3,5-三嗪类化合物的制备方法。
为实现上述目的,本发明采用如下技术方案:
一种式(III)所示的2-芳胺-4-二甲胺-1,3,5-三嗪类化合物的制备方法,所述的制备方法为:
在反应容器中,加入式(I)所示化合物、式(II)所示化合物、金属铜催化剂、配体、碱性物质和溶剂,在80~140℃下搅拌反应6~14h,之后反应液经后处理,制得式(III)所示产物;所述式(I)所示化合物与式(II)所示化合物、金属铜催化剂、配体、碱性物质的投料物质的量之比为1:0.5~3.0:0.1~0.5:0.3~1.2:2.0~4.0;
式(I)、式(II)或式(III)中,
R1为C6~C10芳基或被一个或多个取代基取代的C6~C12芳烷基,所述的取代基为C1~C3烷氧基,优选苯基或3,4-二甲氧基苄基;
R2为氢或C1~C3烷氧基,优选氢或甲氧基;
X为卤素,优选为碘或氯。
本发明所述制备方法中,所述的溶剂可以为氰类,具体优选乙腈;推荐所述溶剂的体积用量以式(I)所示化合物的质量计为10~50mL/g。
所述的金属铜催化剂可以为铜的卤化物,具体优选碘化亚铜。
所述的配体可以为有机胺类,具体优选N,N'-二甲基乙二胺。
所述的碱性物质可以为无机碱,具体优选碳酸钾。
通常所述后处理的方法为:反应结束后,加氨水(至反应液中的固体物质完全溶解),再加饱和NaCl水溶液,用乙酸乙酯萃取,合并有机层,浓缩后进行柱层析分离,以石油醚/乙酸乙酯体积比为5:1的混合液作为洗脱剂,收集含目标化合物的洗脱液,减压蒸除溶剂并干燥,得到目标化合物(III)。
本发明的有益效果在于:
本发明开发了一种2-芳胺-4-二甲胺-1,3,5-三嗪类化合物的制备方法,该工艺反应条件温和,操作方便,成本低,有着广泛的工业应用前景。
(四)具体实施方式
下面通过具体实施例对本发明作进一步的说明,但本发明的保护范围并不仅限于此。
实施例1:化合物(III-1)的制备
在反应容器中,加入2-氨基-4-二甲胺基-6-苯基-1,3,5-三嗪(0.1076g,0.50mmol),碘苯(0.1539g,0.75mmol),碘化亚铜(0.0285g,0.15mmol),碳酸钾(0.1380g,1.00mmol),N,N'-二甲基乙二胺(DMEDA,0.0396g,0.45mmol)和溶剂乙腈(3mL),回流反应10小时。反应结束后冷却,加氨水4mL,搅拌5分钟,再加饱和NaCl水溶液(20mL),用乙酸乙酯萃取(20mL×3),合并有机层,浓缩,柱层析(洗脱剂为石油醚:乙酸乙酯=5:1,v:v),收集Rf值0.4~0.45的洗脱液(TLC监测,展开剂同洗脱剂),减压蒸馏除去溶剂,干燥得目标化合物(III-1)0.1033g,收率为71.0%。1H NMR(500MHz,CDCl3):δ8.46-8.44(m,2H),7.71(d,J=7.7Hz,2H),7.54-7.47(m,3H),7.38-7.35(m,2H),7.21(br,1H),7.08(t,J=7.4Hz,1H),3.36(s,3H),3.26(s,3H).
实施例2:
将DMEDA用量改为0.0132g(0.15mmol),其他操作同实施例1,得量0.0727g,收率50%。
实施例3:
将DMEDA用量改为0.0528g(0.60mmol),其他操作同实施例1,得量0.0975g,收率为69%。
实施例4:
将反应时间改为14小时,其他操作同实施例1,得量0.0945g,收率65%。
实施例5:
将反应时间改为6小时,其他操作同实施例1,得量0.048g,收率33%。
实施例6:
将碘苯的量改为(0.051g,0.25mmol),其他操作同实施例1,得量0.016g,收率11%。
实施例7:
将碘苯的量改为(0.306g,1.5mmol),其他操作同实施例1,得量0.094g,收率65%。
实施例8:
将碘化亚铜的量改为(0.01g,0.05mmol),其他操作同实施例1,得量0.022g,收率15%。
实施例9:
将碘化亚铜的量改为(0.05g,0.25mmol),其他操作同实施例1,得量0.097g,收率66%。
实施例10:
将碳酸钾的量改为(0.267g,2.0mmol),其他操作同实施例1,得量0.081g,收率55%。
实施例11:化合物(III-2)的制备
操作同实施例1,只是将2-氨基-4-二甲胺基-6-苯基-1,3,5-三嗪换成2-氨基-4-二甲胺基-6-(3,4-二甲氧基苄基)-1,3,5-三嗪(0.1375g,0.50mmol),将碘苯换成对碘苯甲醚(0.1755g,0.75mmol),制得目标化合物(III-2),0.1215g,收率为61.0%。
1H NMR(500MHz,CDCl3):δ7.48(d,J=9.0Hz,2H),7.00(d,J=1.5Hz,1H),6.94-6.92(m,2H),6.86(d,J=9.0Hz,2H),6.82(d,J=8.0Hz,1H),3.88(s,3H),3.87(s,3H),3.80(s,3H),3.79(s,2H),3.21(s,3H),3.15(s,3H).
实施例12:
操作同实施例1,只是将碘苯换成溴苯(0.0782g,0.5mmol),制得目标化合物(III-1),0.1004g,收率为69.0%。
实施例13:
操作同实施例1,只是将碘苯换成氯苯(0.0568g,0.5mmol),油浴140℃封管反应,制得目标化合物(III-3),0.0080g,收率为5.5%。
Claims (9)
1.一种式(III)所示的2-芳胺-4-二甲胺-1,3,5-三嗪类化合物的制备方法,其特征在于,所述的制备方法为:
在反应容器中,加入式(I)所示化合物、式(II)所示化合物、金属铜催化剂、配体、碱性物质和溶剂,在80~140℃下搅拌反应6~14h,之后反应液经后处理,制得式(III)所示产物;
所述式(I)所示化合物与式(II)所示化合物、金属铜催化剂、配体、碱性物质的投料物质的量之比为1:0.5~3.0:0.1~0.5:0.3~1.2:2.0~4.0;
所述的配体为N,N'-二甲基乙二胺;
式(I)、式(II)或式(III)中,
R1为C6~C10芳基或被一个或多个取代基取代的C6~C12芳烷基,所述的取代基为C1~C3烷氧基;
R2为氢或C1~C3烷氧基;
X为卤素。
2.如权利要求1所述的制备方法,其特征在于,所述的R1为苯基或3,4-二甲氧基苄基。
3.如权利要求1所述的制备方法,其特征在于,所述的R2为氢或甲氧基。
4.如权利要求1所述的制备方法,其特征在于,所述的X为碘或氯。
5.如权利要求1所述的制备方法,其特征在于,所述的溶剂为乙腈。
6.如权利要求1所述的制备方法,其特征在于,所述溶剂的体积用量以式(I)所示化合物的质量计为10~50mL/g。
7.如权利要求1所述的制备方法,其特征在于,所述的金属铜催化剂为碘化亚铜。
8.如权利要求1所述的制备方法,其特征在于,所述的碱性物质为碳酸钾。
9.如权利要求1所述的制备方法,其特征在于,所述后处理的方法为:反应结束后,加氨水,再加饱和NaCl水溶液,用乙酸乙酯萃取,合并有机层,浓缩后进行柱层析分离,以石油醚/乙酸乙酯体积比为5:1的混合液作为洗脱剂,收集含目标化合物的洗脱液,减压蒸除溶剂并干燥,得到目标化合物(III)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610178273.4A CN105732528B (zh) | 2016-03-25 | 2016-03-25 | 2-芳胺-4-二甲胺-1,3,5-三嗪类化合物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610178273.4A CN105732528B (zh) | 2016-03-25 | 2016-03-25 | 2-芳胺-4-二甲胺-1,3,5-三嗪类化合物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105732528A true CN105732528A (zh) | 2016-07-06 |
CN105732528B CN105732528B (zh) | 2018-11-13 |
Family
ID=56251491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610178273.4A Active CN105732528B (zh) | 2016-03-25 | 2016-03-25 | 2-芳胺-4-二甲胺-1,3,5-三嗪类化合物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105732528B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107033093A (zh) * | 2017-06-07 | 2017-08-11 | 浙江工业大学 | N‑取代磺酰胺类化合物及其制备方法与应用 |
CN108276351A (zh) * | 2018-02-11 | 2018-07-13 | 天津大学 | 具有潜在抗癌效果化合物及其测定方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1246851A (zh) * | 1997-02-10 | 2000-03-08 | 赫彻斯特-舍林农业发展有限公司 | 2,4-二氨基-1,3,5-三嗪,其制备方法及作为除草剂及植物生长调节剂的用途 |
CN105384702A (zh) * | 2015-12-11 | 2016-03-09 | 浙江大学 | 三取代均三嗪类化合物及其制备方法 |
CN105399695A (zh) * | 2015-12-11 | 2016-03-16 | 浙江大学 | 三嗪类化合物及其制备方法和用途 |
-
2016
- 2016-03-25 CN CN201610178273.4A patent/CN105732528B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1246851A (zh) * | 1997-02-10 | 2000-03-08 | 赫彻斯特-舍林农业发展有限公司 | 2,4-二氨基-1,3,5-三嗪,其制备方法及作为除草剂及植物生长调节剂的用途 |
CN105384702A (zh) * | 2015-12-11 | 2016-03-09 | 浙江大学 | 三取代均三嗪类化合物及其制备方法 |
CN105399695A (zh) * | 2015-12-11 | 2016-03-16 | 浙江大学 | 三嗪类化合物及其制备方法和用途 |
Non-Patent Citations (5)
Title |
---|
DEPING WANG,等: "Ligand free copper-catalyzed N-arylation of heteroarylamines", 《TETRAHEDRON LETTERS》 * |
EN-CHIUAN CHANG,等: "Synthesis of 5-arylamino-1-arylpyrazoles from 5-aminopyrazoles with arylhalides via CuI catalyzed Ullman coupling reaction", 《TETRAHEDRON》 * |
JITENDRA C. KAILA,等: "A convenient one-pot synthesis of trisubstituted 1,3,5-triazines through intermediary amidinothioureas", 《TETRAHEDRON LETTERS》 * |
PASCAL DAO,等: "High yielding microwave-assisted synthesis of tri-substituted 1,3,5-triazines using Pd-catalyzed aryl and heteroarylamination", 《TETRAHEDRON》 * |
高培森,等: "碘化亚铜/羧酸催化氧接双三嗪高效合成方法", 《中国化学会第29届学术年会摘要集》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107033093A (zh) * | 2017-06-07 | 2017-08-11 | 浙江工业大学 | N‑取代磺酰胺类化合物及其制备方法与应用 |
CN107033093B (zh) * | 2017-06-07 | 2019-09-03 | 浙江工业大学 | N-取代磺酰胺类化合物及其制备方法与应用 |
CN108276351A (zh) * | 2018-02-11 | 2018-07-13 | 天津大学 | 具有潜在抗癌效果化合物及其测定方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105732528B (zh) | 2018-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2216331B1 (en) | A successive preparation method of 3-isothiazolone derivates and their intermediates | |
CN103992225B (zh) | 一种水杨醛衍生物及其制备方法 | |
CN107880079B (zh) | 环状氮杂环双卡宾钯配合物及其制备方法与用途 | |
CN104592281A (zh) | 双官能团4-tms-5-i-1,2,3-三氮唑类化合物及其制备方法和应用 | |
CN105732528A (zh) | 2-芳胺-4-二甲胺-1,3,5-三嗪类化合物的制备方法 | |
CN114456121B (zh) | 一种1,2,4-三氮唑衍生物的合成方法 | |
CN104411704B (zh) | 制备三唑化合物的方法 | |
CN102250016B (zh) | 一种4,5,6-三氯嘧啶的制备方法 | |
CN108658717A (zh) | 一种脱羧反应制备三取代烯烃的合成方法 | |
CN105646360A (zh) | 基于联二萘酚链接的氮杂环卡宾金属配合物及其制备方法与应用 | |
CN106831599B (zh) | 一种合成1-二氟甲基咪唑及其衍生物的方法 | |
CN102030710A (zh) | 杀菌剂唑菌酯14c标记化合物的合成方法 | |
CN103254136B (zh) | 一种制备四[4-(1-咪唑基)苯基]甲烷的方法 | |
CN107652206A (zh) | 一种苊基骨架大位阻α‑二亚胺化合物及其合成方法 | |
US8791301B2 (en) | Method of preparing secondary amine compound using microflow reactor | |
CN103232478B (zh) | 基于双齿苯并咪唑配体的金属配合物及其制备方法与用途 | |
WO2019040585A1 (en) | METHODS OF PRODUCING PF1022A DERIVATIVES AND FLOW PLATFORMS USEFUL THEREFOR | |
CN104447336A (zh) | 一种三碟烯衍生物及其制备方法 | |
CN107573352A (zh) | 环状双苯并咪唑六氟磷酸盐化合物及其制备方法与应用 | |
CN101544613B (zh) | 一种均三嗪衍生物及该衍生物的制备方法及该衍生物在对胸腺嘧啶识别中的应用 | |
CN105294416B (zh) | 一种1,5‑二羰基衍生物及其制备方法 | |
CN109180520B (zh) | 一种银催化合成官能化苯并芴类化合物的方法 | |
CN108840806B (zh) | 一种苯甲酰胺类化合物的制备方法 | |
CN107936034B (zh) | 苄氧基二苯并[b,f]噁庚英环丙烯酸类化合物与中间体及其应用 | |
CN104774183A (zh) | 一种甲酰基瑞舒伐汀钙中间体的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Song Chan Inventor after: Cui Dongmei Inventor after: Li Jinjing Inventor after: Zhang Chen Inventor before: Cui Dongmei Inventor before: Song Chan Inventor before: Li Jinjing Inventor before: Zhang Chen |
|
CB03 | Change of inventor or designer information |